SCHEMBL28794896

SCHEMBL28794896

O=C(O)c1ccc2[nH]cc(C(=O)OCc3ccccc3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
GABRA1 P14867 2/20 0.49
GABRB2 P47870 2/20 0.49
GABRB1 P18505 1/20 0.49
GABRA3 P34903 1/20 0.49
NR4A2 P43354 2/20 0.48
LMNA P02545 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
KMT2A Q03164 2/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HTR7 P34969 1/20 0.47
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MDH2 P40926 1/20 0.46
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835246 0.87 TDP1 (0.52) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL16920143 0.85 NR4A2 (0.61) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL22479157 0.85 GABRA1 (0.49) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL3264030 0.84 NR4A2 (0.61) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL2807092 0.81 CTNNB1 (0.49) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL10208253 0.80 KMT2A (0.51) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL14793753 0.79 TDP1 (0.52) ALDH1A1GABRA1GABRB2GABRB1GABRA3
SCHEMBL27853699 0.79 F7 (0.66) ALDH1A1NR4A2LMNAHTR7HPGD
SCHEMBL4485057 0.78 NR4A2 (0.68) ALDH1A1NR4A2LMNAKMT2AHTR7
SCHEMBL4941110 0.78 ALDH1A1 (0.68) ALDH1A1NR4A2LMNATDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102358741-A Azepinoindole derivatives as pharmaceutical agents EXELIXIS INC 2012-02-22 CN disclosed